Quick Answer
Glucotrack, Inc. reported Diluted EPS of $31.22 per share for fiscal year 2025.
Glucotrack, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $31.22 | -99.2% |
| 2024 | $4106.00 | +11912.9% |
| 2023 | $34.18 | +11686.2% |
| 2022 | $0.29 | +11.5% |
| 2021 | $0.26 | +36.8% |
| 2020 | $0.19 | +1050.0% |
| 2019 | -$0.02 | +99.6% |
| 2018 | -$4.74 | -153.5% |
| 2017 | -$1.87 | -73.1% |
| 2016 | -$1.08 | +6.1% |
| 2015 | -$1.15 | -410.8% |
| 2014 | $0.37 | +119.0% |
| 2013 | -$1.95 | -275.0% |
| 2012 | -$0.52 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.64 | -99.6% | -51.8% |
| June 30, 2025 | $9.62 | -99.0% | +1535.8% |
| March 31, 2025 | -$0.67 | +94.3% | -100.1% |
| September 30, 2024 | $1092.00 | +222957.1% | +11.0% |
| June 30, 2024 | $984.00 | +364344.4% | +8488.7% |
| March 31, 2024 | -$11.73 | -14562.5% | -2293.9% |
| September 30, 2023 | -$0.49 | -716.7% | -281.5% |
| June 30, 2023 | $0.27 | +485.7% | +437.5% |
- Glucotrack, Inc. showed a decrease of -99.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2025 period, Glucotrack, Inc.’s diluted eps has grown by 6103.8% (from $0.52 per share (loss) to $31.22 per share).
- The most recent figure is from Glucotrack, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: